...
首页> 外文期刊>The biochemical journal >Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-l-Pro-l-aminohexanoic acid
【24h】

Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-l-Pro-l-aminohexanoic acid

机译:膦酰胺肽N-(苯乙基膦酰基)-Gly-1-Pro-1-氨基己酸对内肽酶24.16和内肽酶24.15的有效抑制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

pA phosphonamide peptide, N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid, previously shown to block Clostridium histolyticum collagenases, was examined as a putative inhibitor of endopeptidase 24.16 and endopeptidase 24.15. Hydrolysis of two endopeptidase 24.16 substrates, i.e. 3-carboxy-7-methoxycoumarin (Mcc)-Pro-Leu-Gly-Pro-D-Lys-dinitrophenyl (Dnp) and neurotensin, were completely and dose-dependently inhibited by the phosphonamide inhibitor with KI values of 0.3 and 0.9 nM respectively. In addition, the phosphonamide peptide inhibited the hydrolysis of benzoyl (Bz)-Gly-Ala-Ala-Phe-(pAB) p-aminobenzoate and neurotensin by endopeptidase 24.15 with about a 10-fold lower potency (KI values of 5 and 7.5 nM respectively). The selectivity of this inhibitor towards several exo- and endo-peptidases belonging to the zinc-containing metallopeptidase family established that a 1 microM concentration of this inhibitor was unable to affect leucine aminopeptidase, carboxypeptidase A, angiotensin-converting enzyme and endopeptidase 24.11. The present paper therefore reports on the first hydrophilic highly potent endopeptidase 24.16 inhibitor and describes the most potent inhibitory agent directed towards endopeptidase 24.15 developed to date. These tools should allow one to assess the contribution of endopeptidase 24.16 and endopeptidase 24.15 to the physiological inactivation of neurotensin as well as other neuropeptides./p
机译:先前已证明其阻断溶组织梭状芽孢杆菌胶原酶的膦酰胺肽N-(苯乙基膦酰基)-Gly-L-Pro-L-氨基己酸作为内肽酶24.16和内肽酶24.15的假定抑制剂被检查。膦酰胺抑制剂可完全和剂量依赖性地抑制两种内肽酶24.16底物的水解,即3-羧基-7-甲氧基香豆素(Mcc)-Pro-Leu-Gly-Pro-D-Lys-二硝基苯基(Dnp)和神经降压素。 KI值分别为0.3和0.9 nM。此外,膦酰胺肽通过内肽酶24.15抑制苯甲酰基(Bz)-Gly-Ala-Ala-Pla-(pAB)对氨基苯甲酸酯和神经降压素的水解,效力降低约10倍(KI值分别为5和7.5 nM)分别)。该抑制剂对几种属于含锌金属肽酶家族的外切肽酶和内切肽酶的选择性确定了该浓度为1 microM的该抑制剂不能影响亮氨酸氨肽酶,羧肽酶A,血管紧张素转化酶和内肽酶24.11。因此,本论文报道了第一种亲水性高效内肽酶24.16抑制剂,并描述了迄今为止开发的针对内肽酶24.15的最有效抑制剂。这些工具应使人们能够评估内肽酶24.16和内肽酶24.15对神经降压素以及其他神经肽的生理失活的贡献。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号